Your browser doesn't support javascript.
loading
Letter: real-world use of terlipressin in patients with the hepatorenal syndrome-authors' reply.
Allegretti, Andrew S; Jamil, Khurram; Moore, Kevin.
Affiliation
  • Allegretti AS; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Jamil K; Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
  • Moore K; UCL Institute of Liver and Digestive Health, Royal Free Hospital, University College London, London, UK.
Aliment Pharmacol Ther ; 54(3): 350-351, 2021 08.
Article in En | MEDLINE | ID: mdl-34236097
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatorenal Syndrome Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatorenal Syndrome Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido